ECSP11011384A - Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh. - Google Patents
Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh.Info
- Publication number
- ECSP11011384A ECSP11011384A EC2011011384A ECSP11011384A ECSP11011384A EC SP11011384 A ECSP11011384 A EC SP11011384A EC 2011011384 A EC2011011384 A EC 2011011384A EC SP11011384 A ECSP11011384 A EC SP11011384A EC SP11011384 A ECSP11011384 A EC SP11011384A
- Authority
- EC
- Ecuador
- Prior art keywords
- addition salts
- azabifenylaminobenzoic
- trometamine
- acid derivatives
- dhodh inhibitors
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 108010052167 Dihydroorotate Dehydrogenase Proteins 0.000 title 1
- 102100032823 Dihydroorotate dehydrogenase (quinone), mitochondrial Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000006645 (C3-C4) cycloalkyl group Chemical group 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 methoxy, ethoxy, isopropoxy Chemical group 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
- 229960000281 trometamol Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a nuevas sales de adición cristalinas de (i) trometamina con (ii) un derivado de ácido azabifenilaminobenzoico de fórmula (I) en la queR1 se selecciona del grupo que consiste en alquilo C1-C4, cicloalquilo C3-C4 y CF3, G1 se selecciona de átomos de nitrógeno y grupos CH, C(CH3) y C(CF3), y G2 representa un grupo fenilo opcionalmente sustituido con uno o dos sustituyentes seleccionados de cloro, fluoro, metoxi, etoxi, isopropoxi, trifluorometoxi, CF3, y CONR7R8, en donde R7 es hidrógeno y R8 es ciclopropilo o R7 y R8 junto con el átomo de nitrógeno al que están unidos forman un grupo de fórmuladonde n es 1.y sus solvatos farmacéuticamente aceptables.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09382032A EP2230232A1 (en) | 2009-03-13 | 2009-03-13 | Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP11011384A true ECSP11011384A (es) | 2011-11-30 |
Family
ID=40671396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2011011384A ECSP11011384A (es) | 2009-03-13 | 2011-10-07 | Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20120003183A1 (es) |
| EP (2) | EP2230232A1 (es) |
| JP (1) | JP2012520251A (es) |
| KR (1) | KR20110126695A (es) |
| CN (1) | CN102341372A (es) |
| AR (1) | AR075737A1 (es) |
| AU (1) | AU2010223527A1 (es) |
| CA (1) | CA2754785A1 (es) |
| CL (1) | CL2011002213A1 (es) |
| CO (1) | CO6501157A2 (es) |
| EA (1) | EA201101298A1 (es) |
| EC (1) | ECSP11011384A (es) |
| IL (1) | IL214517A0 (es) |
| MX (1) | MX2011009147A (es) |
| NZ (1) | NZ594491A (es) |
| PE (1) | PE20120328A1 (es) |
| SG (2) | SG173824A1 (es) |
| TW (1) | TW201033177A (es) |
| UY (1) | UY32465A (es) |
| WO (1) | WO2010102825A1 (es) |
| ZA (1) | ZA201105743B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
| EP2135610A1 (en) * | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
| EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
| EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
| HRP20211462T1 (hr) | 2017-04-24 | 2021-12-24 | Aurigene Discovery Technologies Limited | Postupci uporabe za trisupstituirane derivate benzotriazola kao inhibitora dihidroorotatne oksigenaze |
| ES3038736T3 (en) | 2018-02-20 | 2025-10-14 | Servier Lab | Benzotriazole derivative for use in treating double and triple hit diffuse large b cell lymphoma |
| CN110903219A (zh) * | 2018-09-18 | 2020-03-24 | 广东东阳光药业有限公司 | 酰胺衍生物的盐及其制备方法 |
| MX2021007536A (es) | 2018-12-21 | 2021-09-23 | Les Laboratoires Servier Sas | Formas de sal y cristalinas de un compuesto organico y composiciones farmaceuticas del mismo. |
| WO2025227007A1 (en) * | 2024-04-26 | 2025-10-30 | Ohio State Innovation Foundation | Methods and compositions for inhibition of dihydroorotate dehydrogenase |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
| EP1935416A3 (en) | 2001-04-05 | 2008-10-22 | Aventis Pharma Inc | (Z) -2-cyano-3-hydroxybut-2-enoic acid (4'-trifluoromethylphenyl) amide for the treatment of multiple sclerosis |
| PE20030120A1 (es) * | 2001-06-19 | 2003-02-12 | Merck & Co Inc | Sal amina de un antagonista de receptor de integrin |
| MXPA04000224A (es) | 2001-07-10 | 2005-07-25 | 4Sc Ag | Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos. |
| WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
| AU2003300530A1 (en) | 2002-12-23 | 2004-07-14 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
| JP2008500393A (ja) | 2004-05-21 | 2008-01-10 | ザ ユーエービー リサーチ ファンデーション | ピリミジン合成インヒビターに関する組成物および方法 |
| WO2006022442A1 (ja) | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
| WO2006044741A1 (en) | 2004-10-19 | 2006-04-27 | Aventis Pharmaceuticals Inc. | Use of (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease |
| UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
-
2009
- 2009-03-13 EP EP09382032A patent/EP2230232A1/en not_active Withdrawn
-
2010
- 2010-02-24 UY UY0001032465A patent/UY32465A/es unknown
- 2010-03-08 TW TW099106618A patent/TW201033177A/zh unknown
- 2010-03-11 SG SG2011060829A patent/SG173824A1/en unknown
- 2010-03-11 EP EP10708733A patent/EP2406222A1/en not_active Withdrawn
- 2010-03-11 AR ARP100100740A patent/AR075737A1/es not_active Application Discontinuation
- 2010-03-11 MX MX2011009147A patent/MX2011009147A/es not_active Application Discontinuation
- 2010-03-11 AU AU2010223527A patent/AU2010223527A1/en not_active Abandoned
- 2010-03-11 EA EA201101298A patent/EA201101298A1/ru unknown
- 2010-03-11 US US13/256,104 patent/US20120003183A1/en not_active Abandoned
- 2010-03-11 NZ NZ594491A patent/NZ594491A/xx not_active IP Right Cessation
- 2010-03-11 CN CN2010800108779A patent/CN102341372A/zh active Pending
- 2010-03-11 PE PE2011001597A patent/PE20120328A1/es not_active Application Discontinuation
- 2010-03-11 JP JP2011553359A patent/JP2012520251A/ja active Pending
- 2010-03-11 CA CA2754785A patent/CA2754785A1/en not_active Abandoned
- 2010-03-11 SG SG10201400568PA patent/SG10201400568PA/en unknown
- 2010-03-11 WO PCT/EP2010/001549 patent/WO2010102825A1/en not_active Ceased
- 2010-03-11 KR KR1020117021320A patent/KR20110126695A/ko not_active Withdrawn
-
2011
- 2011-08-04 ZA ZA2011/05743A patent/ZA201105743B/en unknown
- 2011-08-08 IL IL214517A patent/IL214517A0/en unknown
- 2011-09-01 CO CO11112331A patent/CO6501157A2/es active IP Right Grant
- 2011-09-08 CL CL2011002213A patent/CL2011002213A1/es unknown
- 2011-10-07 EC EC2011011384A patent/ECSP11011384A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20110126695A (ko) | 2011-11-23 |
| EP2230232A1 (en) | 2010-09-22 |
| CA2754785A1 (en) | 2010-09-16 |
| UY32465A (es) | 2010-05-31 |
| NZ594491A (en) | 2013-11-29 |
| US20120003183A1 (en) | 2012-01-05 |
| JP2012520251A (ja) | 2012-09-06 |
| SG10201400568PA (en) | 2014-07-30 |
| CO6501157A2 (es) | 2012-08-15 |
| SG173824A1 (en) | 2011-09-29 |
| AU2010223527A1 (en) | 2011-08-25 |
| AR075737A1 (es) | 2011-04-20 |
| IL214517A0 (en) | 2011-09-27 |
| PE20120328A1 (es) | 2012-03-29 |
| MX2011009147A (es) | 2011-09-15 |
| EP2406222A1 (en) | 2012-01-18 |
| EA201101298A1 (ru) | 2012-04-30 |
| ZA201105743B (en) | 2012-04-25 |
| TW201033177A (en) | 2010-09-16 |
| WO2010102825A1 (en) | 2010-09-16 |
| CN102341372A (zh) | 2012-02-01 |
| CL2011002213A1 (es) | 2012-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP11011384A (es) | Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh. | |
| ECSP10010337A (es) | Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica | |
| CO6321276A2 (es) | Derivados de tiazol usados como inhibidores de pi3- cinasa | |
| AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
| AR082112A1 (es) | Derivados de imidazopiridina, su procedimiento de preparacion y su aplicacion en terapeutica | |
| AR081426A1 (es) | Derivados de pirazol inhibidores del receptor sigma | |
| CO6420337A2 (es) | Sales de adición de aminas que contienen grupos hidroxilo y/o carboxílicos con derivados de ácido aminonicotínico como inhibidores de dhodh | |
| DOP2010000227A (es) | Derivados biciclicos de carboxamidas aza-biciclicas, su preparacion y su aplicacion terapeutica | |
| UY39338A (es) | Derivados de piperidinona como inhibidores mdm2, composiciones farmacéuticas que los contienen y sus usos | |
| ECSP10010405A (es) | Procesos e intermediarios para la preparacion de derivados de acido 5-bifenil-4-il-2-metilpentanoico | |
| UY33226A (es) | Compuestos de pirrolopirimidina deuterada como inhibidores de la cdk4/6 | |
| AR082768A1 (es) | Derivados de indolizina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen | |
| AR083903A1 (es) | Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos | |
| AR072803A1 (es) | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes | |
| NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| BR112013017416A2 (pt) | derivado de indola ou indazola ou sal do mesmo | |
| CR20130476A (es) | Derivados de pirazolidin-3-ona | |
| UY32246A (es) | Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica | |
| ES2572052T3 (es) | Amidas macrocíclicas como inhibidores de proteasas | |
| ES2570659T3 (es) | Agonistas de adenosina A1 para el tratamiento del glaucoma y de la hipertensión ocular | |
| AR085542A1 (es) | Compuestos de azaespirodecanona como inhibidores de hsl | |
| AR082973A1 (es) | Derivados de dihidrobenzoxatiazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR074514A1 (es) | Derivados de morfina-6-glucuronido, su preparacion y su aplicacion en terapeutica | |
| AR080102A1 (es) | Compuestos de aril-bencil-amina y su utilizacion en el tratamiento de trastornos mediados por las interacciones de los linfocitos | |
| HK1161589A (en) | Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |